{"active":true,"archived":false,"automaticallyActive":true,"closed":false,"commentCount":0,"competitive":0.3138485680659082,"createdAt":"2026-02-05T17:24:56.296918Z","creationDate":"2026-02-05T19:15:59.686619Z","cyom":false,"deploying":false,"deployingTimestamp":"2026-02-05T19:10:44.72437Z","description":"This market will resolve based on Agomab Therapeutics’ market capitalization at the closing price on its first day of trading.\n\nAs of market creation, the IPO is scheduled to price on February 6, 2026 (ET). If no such IPO occurs by March 31, 2026, 11:59 PM ET, the market will resolve to \"No IPO before April 2026\".\n\nMarket capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.\n\nIf the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.\n\nResolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.\n\nIn the event of an interruption in the course of the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.","enableNegRisk":true,"enableOrderBook":true,"endDate":"2026-02-06T00:00:00Z","featured":false,"gmpChartMode":"default","icon":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","id":"199534","image":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","liquidity":1549.6379,"liquidityClob":1549.6379,"markets":[{"acceptingOrders":true,"acceptingOrdersTimestamp":"2026-02-05T19:13:53Z","active":true,"approved":true,"archived":false,"automaticallyActive":true,"bestAsk":0.8,"bestBid":0.01,"clearBookOnStart":true,"clobRewards":[{"assetAddress":"0x2791Bca1f2de4661ED88A30C99A7a9449Aa84174","conditionId":"0xb7d362f3fca894ac33ee0780899c50b69c2140108bd175a93e37319e9bfee470","endDate":"2500-12-31","id":"72909","rewardsAmount":0,"rewardsDailyRate":60,"startDate":"2026-02-06"}],"clobTokenIds":"[\"35733497246709222507259646033096292000870511792451861653698846930609160602066\", \"30413260126774193572407556464150294047007827802712860959203703993882363612310\"]","closed":false,"competitive":0.20812170164267485,"conditionId":"0xb7d362f3fca894ac33ee0780899c50b69c2140108bd175a93e37319e9bfee470","createdAt":"2026-02-05T17:25:04.113445Z","customLiveness":0,"cyom":false,"deploying":false,"deployingTimestamp":"2026-02-05T19:11:54.846614Z","description":"This market will resolve based on Agomab Therapeutics’ market capitalization at the closing price on its first day of trading.\n\nAs of market creation, the IPO is scheduled to price on February 6, 2026 (ET). If no such IPO occurs by March 31, 2026, 11:59 PM ET, the market will resolve to \"No IPO before April 2026\".\n\nMarket capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.\n\nIf the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.\n\nResolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.\n\nIn the event of an interruption in the course of the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.","enableOrderBook":true,"endDate":"2026-02-06T00:00:00Z","endDateIso":"2026-02-06","featured":false,"feesEnabled":false,"funded":false,"groupItemThreshold":"5","groupItemTitle":"1.0B+","hasReviewedDates":true,"holdingRewardsEnabled":false,"icon":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","id":"1340744","image":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","lastTradePrice":0.02,"liquidity":"316.6198","liquidityClob":316.6198,"liquidityNum":316.6198,"manualActivation":false,"marketMakerAddress":"","negRisk":true,"negRiskMarketID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3400","negRiskOther":false,"negRiskRequestID":"0x978755005bc098fca1308c47a385f9c17cccaeb6e020532ba99ac409483746e7","new":false,"oneDayPriceChange":-0.94,"orderMinSize":5,"orderPriceMinTickSize":0.01,"outcomePrices":"[\"0.405\", \"0.595\"]","outcomes":"[\"Yes\", \"No\"]","pagerDutyNotificationEnabled":false,"pendingDeployment":false,"question":"Will Agomab Therapeutics NV's market cap be greater than $1.0B at market close on IPO day?","questionID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3405","ready":false,"requiresTranslation":false,"resolvedBy":"0x2F5e3684cb1F318ec51b00Edba38d79Ac2c0aA9d","restricted":true,"rewardsMaxSpread":4.5,"rewardsMinSize":50,"rfqEnabled":false,"showGmpOutcome":false,"showGmpSeries":false,"slug":"will-agomab-therapeutics-nvs-market-cap-be-greater-than-1pt0b-at-market-close-on-ipo-day","spread":0.79,"startDate":"2026-02-05T19:14:59.441729Z","startDateIso":"2026-02-05","submitted_by":"0x91430CaD2d3975766499717fA0D66A78D814E5c5","umaBond":"500","umaResolutionStatuses":"[]","umaReward":"5","updatedAt":"2026-02-06T06:40:39.265323Z","volume":"50","volume1mo":50,"volume1moClob":50,"volume1wk":50,"volume1wkClob":50,"volume1yr":50,"volume1yrClob":50,"volume24hr":50,"volume24hrClob":50,"volumeClob":50,"volumeNum":50},{"acceptingOrders":true,"acceptingOrdersTimestamp":"2026-02-05T19:13:21Z","active":true,"approved":true,"archived":false,"automaticallyActive":true,"bestAsk":0.9,"bestBid":0.03,"clearBookOnStart":true,"clobRewards":[{"assetAddress":"0x2791Bca1f2de4661ED88A30C99A7a9449Aa84174","conditionId":"0xb2ff8a4f7f741fb1c251e31a4fd7bf3a2c5f1fb17a4ea070afc56817087d8885","endDate":"2500-12-31","id":"72906","rewardsAmount":0,"rewardsDailyRate":100,"startDate":"2026-02-06"}],"clobTokenIds":"[\"111237025430048166019064681592595272030098972317285708278760374104308084863577\", \"92422566133720704879624334428957058351364368523650960445672248987540714169157\"]","closed":false,"competitive":0.12984094484256786,"conditionId":"0xb2ff8a4f7f741fb1c251e31a4fd7bf3a2c5f1fb17a4ea070afc56817087d8885","createdAt":"2026-02-05T17:24:58.384688Z","customLiveness":0,"cyom":false,"deploying":false,"deployingTimestamp":"2026-02-05T19:11:54.838581Z","description":"This market will resolve based on Agomab Therapeutics’ market capitalization at the closing price on its first day of trading.\n\nAs of market creation, the IPO is scheduled to price on February 6, 2026 (ET). If no such IPO occurs by March 31, 2026, 11:59 PM ET, the market will resolve to \"No IPO before April 2026\".\n\nMarket capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.\n\nIf the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.\n\nResolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.\n\nIn the event of an interruption in the course of the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.","enableOrderBook":true,"endDate":"2026-02-06T00:00:00Z","endDateIso":"2026-02-06","featured":false,"feesEnabled":false,"funded":false,"groupItemThreshold":"0","groupItemTitle":"<600M","hasReviewedDates":true,"holdingRewardsEnabled":false,"icon":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","id":"1340739","image":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","liquidity":"152.9596","liquidityClob":152.9596,"liquidityNum":152.9596,"manualActivation":false,"marketMakerAddress":"","negRisk":true,"negRiskMarketID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3400","negRiskOther":false,"negRiskRequestID":"0x2c8f99fa7ddd5445f97a904a04fc8d9c98beb6df6adb59d240d3681a47225abe","new":false,"orderMinSize":5,"orderPriceMinTickSize":0.01,"outcomePrices":"[\"0.465\", \"0.535\"]","outcomes":"[\"Yes\", \"No\"]","pagerDutyNotificationEnabled":false,"pendingDeployment":false,"question":"Will Agomab Therapeutics NV's market cap be less than $600M at market close on IPO day?","questionID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3400","ready":false,"requiresTranslation":false,"resolvedBy":"0x2F5e3684cb1F318ec51b00Edba38d79Ac2c0aA9d","restricted":true,"rewardsMaxSpread":4.5,"rewardsMinSize":50,"rfqEnabled":false,"showGmpOutcome":false,"showGmpSeries":false,"slug":"will-agomab-therapeutics-nvs-market-cap-be-less-than-600m-at-market-close-on-ipo-day","spread":0.87,"startDate":"2026-02-05T19:14:27.97253Z","startDateIso":"2026-02-05","submitted_by":"0x91430CaD2d3975766499717fA0D66A78D814E5c5","umaBond":"500","umaResolutionStatuses":"[]","umaReward":"5","updatedAt":"2026-02-06T06:40:31.264157Z","volume":"50","volume1mo":50,"volume1moClob":50,"volume1wk":50,"volume1wkClob":50,"volume1yr":50,"volume1yrClob":50,"volume24hr":50,"volume24hrClob":50,"volumeClob":50,"volumeNum":50},{"acceptingOrders":true,"acceptingOrdersTimestamp":"2026-02-05T19:13:27Z","active":true,"approved":true,"archived":false,"automaticallyActive":true,"bestAsk":0.7,"bestBid":0.02,"clearBookOnStart":true,"clobRewards":[{"assetAddress":"0x2791Bca1f2de4661ED88A30C99A7a9449Aa84174","conditionId":"0x4012b5fc3c4ffdf8c0b32efa44fc4056ad5ced6894cc493de3380ba3f8b77b5f","endDate":"2500-12-31","id":"72899","rewardsAmount":0,"rewardsDailyRate":46,"startDate":"2026-02-06"}],"clobTokenIds":"[\"23301489830590805088817924846307477215979088574390115826726653582098395177075\", \"74911590492600420499297065591301921175637694204966772587969879737408045344144\"]","closed":false,"competitive":0.3138485680659082,"conditionId":"0x4012b5fc3c4ffdf8c0b32efa44fc4056ad5ced6894cc493de3380ba3f8b77b5f","createdAt":"2026-02-05T17:24:59.415197Z","customLiveness":0,"cyom":false,"deploying":false,"deployingTimestamp":"2026-02-05T19:11:54.840446Z","description":"This market will resolve based on Agomab Therapeutics’ market capitalization at the closing price on its first day of trading.\n\nAs of market creation, the IPO is scheduled to price on February 6, 2026 (ET). If no such IPO occurs by March 31, 2026, 11:59 PM ET, the market will resolve to \"No IPO before April 2026\".\n\nMarket capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.\n\nIf the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.\n\nResolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.\n\nIn the event of an interruption in the course of the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.","enableOrderBook":true,"endDate":"2026-02-06T00:00:00Z","endDateIso":"2026-02-06","featured":false,"feesEnabled":false,"funded":false,"groupItemThreshold":"1","groupItemTitle":"600M–700M","hasReviewedDates":true,"holdingRewardsEnabled":false,"icon":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","id":"1340740","image":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","liquidity":"229.8399","liquidityClob":229.8399,"liquidityNum":229.8399,"manualActivation":false,"marketMakerAddress":"","negRisk":true,"negRiskMarketID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3400","negRiskOther":false,"negRiskRequestID":"0x3ca0374229760488e684edcaa163ae1641be2cebaa4afe78c5f6d15828e38465","new":false,"oneDayPriceChange":-0.64,"orderMinSize":5,"orderPriceMinTickSize":0.01,"outcomePrices":"[\"0.36\", \"0.64\"]","outcomes":"[\"Yes\", \"No\"]","pagerDutyNotificationEnabled":false,"pendingDeployment":false,"question":"Will Agomab Therapeutics NV's market cap be between $600M and $700M at market close on IPO day?","questionID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3401","ready":false,"requiresTranslation":false,"resolvedBy":"0x2F5e3684cb1F318ec51b00Edba38d79Ac2c0aA9d","restricted":true,"rewardsMaxSpread":4.5,"rewardsMinSize":50,"rfqEnabled":false,"showGmpOutcome":false,"showGmpSeries":false,"slug":"will-agomab-therapeutics-nvs-market-cap-be-between-600m-and-700m-at-market-close-on-ipo-day","spread":0.68,"startDate":"2026-02-05T19:14:33.690844Z","startDateIso":"2026-02-05","submitted_by":"0x91430CaD2d3975766499717fA0D66A78D814E5c5","umaBond":"500","umaResolutionStatuses":"[]","umaReward":"5","updatedAt":"2026-02-06T06:38:52.175925Z","volume":"50","volume1mo":50,"volume1moClob":50,"volume1wk":50,"volume1wkClob":50,"volume1yr":50,"volume1yrClob":50,"volume24hr":50,"volume24hrClob":50,"volumeClob":50,"volumeNum":50},{"acceptingOrders":true,"acceptingOrdersTimestamp":"2026-02-05T19:13:39Z","active":true,"approved":true,"archived":false,"automaticallyActive":true,"bestAsk":0.85,"bestBid":0.01,"clearBookOnStart":true,"clobRewards":[{"assetAddress":"0x2791Bca1f2de4661ED88A30C99A7a9449Aa84174","conditionId":"0x446a2f47c6fd111a33c2b15cd4921d58c2572648814518f9344d0e61da9fdf1a","endDate":"2500-12-31","id":"72905","rewardsAmount":0,"rewardsDailyRate":72,"startDate":"2026-02-06"}],"clobTokenIds":"[\"19638095089023626330168810431276465458953109150760667029358898151415783516467\", \"69344475437737080831785111167432115275844247403575317087114676005692415653626\"]","closed":false,"competitive":0.15921982286794706,"conditionId":"0x446a2f47c6fd111a33c2b15cd4921d58c2572648814518f9344d0e61da9fdf1a","createdAt":"2026-02-05T17:25:01.230901Z","customLiveness":0,"cyom":false,"deploying":false,"deployingTimestamp":"2026-02-05T19:11:54.843683Z","description":"This market will resolve based on Agomab Therapeutics’ market capitalization at the closing price on its first day of trading.\n\nAs of market creation, the IPO is scheduled to price on February 6, 2026 (ET). If no such IPO occurs by March 31, 2026, 11:59 PM ET, the market will resolve to \"No IPO before April 2026\".\n\nMarket capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.\n\nIf the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.\n\nResolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.\n\nIn the event of an interruption in the course of the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.","enableOrderBook":true,"endDate":"2026-02-06T00:00:00Z","endDateIso":"2026-02-06","featured":false,"feesEnabled":false,"funded":false,"groupItemThreshold":"3","groupItemTitle":"800M–900M","hasReviewedDates":true,"holdingRewardsEnabled":false,"icon":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","id":"1340742","image":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","lastTradePrice":0.02,"liquidity":"212.5596","liquidityClob":212.5596,"liquidityNum":212.5596,"manualActivation":false,"marketMakerAddress":"","negRisk":true,"negRiskMarketID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3400","negRiskOther":false,"negRiskRequestID":"0xbaa124301f7ec89bc60fbff2c2308b1af7342ba9eb83c8e8ba8411a9d7868b19","new":false,"oneDayPriceChange":-0.57,"orderMinSize":5,"orderPriceMinTickSize":0.01,"outcomePrices":"[\"0.43\", \"0.57\"]","outcomes":"[\"Yes\", \"No\"]","pagerDutyNotificationEnabled":false,"pendingDeployment":false,"question":"Will Agomab Therapeutics NV's market cap be between $800M and $900M at market close on IPO day?","questionID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3403","ready":false,"requiresTranslation":false,"resolvedBy":"0x2F5e3684cb1F318ec51b00Edba38d79Ac2c0aA9d","restricted":true,"rewardsMaxSpread":4.5,"rewardsMinSize":50,"rfqEnabled":false,"showGmpOutcome":false,"showGmpSeries":false,"slug":"will-agomab-therapeutics-nvs-market-cap-be-between-800m-and-900m-at-market-close-on-ipo-day","spread":0.84,"startDate":"2026-02-05T19:14:45.326017Z","startDateIso":"2026-02-05","submitted_by":"0x91430CaD2d3975766499717fA0D66A78D814E5c5","umaBond":"500","umaResolutionStatuses":"[]","umaReward":"5","updatedAt":"2026-02-06T06:40:34.586023Z","volume":"50","volume1mo":50,"volume1moClob":50,"volume1wk":50,"volume1wkClob":50,"volume1yr":50,"volume1yrClob":50,"volume24hr":50,"volume24hrClob":50,"volumeClob":50,"volumeNum":50},{"acceptingOrders":true,"acceptingOrdersTimestamp":"2026-02-05T19:13:33Z","active":true,"approved":true,"archived":false,"automaticallyActive":true,"bestAsk":0.85,"bestBid":0.01,"clearBookOnStart":true,"clobRewards":[{"assetAddress":"0x2791Bca1f2de4661ED88A30C99A7a9449Aa84174","conditionId":"0xdd15fc03d6eacf585be93e25191e7cda1b32b3b14a7fef94e9236f6fca3c3550","endDate":"2500-12-31","id":"72904","rewardsAmount":0,"rewardsDailyRate":72,"startDate":"2026-02-06"}],"clobTokenIds":"[\"85476220858272669672493113393797403700727095276842922364743467556603954035612\", \"33182013168074288222727716131494891674100793857702765995640731743672388741093\"]","closed":false,"competitive":0.15921982286794706,"conditionId":"0xdd15fc03d6eacf585be93e25191e7cda1b32b3b14a7fef94e9236f6fca3c3550","createdAt":"2026-02-05T17:25:00.241847Z","customLiveness":0,"cyom":false,"deploying":false,"deployingTimestamp":"2026-02-05T19:11:54.84247Z","description":"This market will resolve based on Agomab Therapeutics’ market capitalization at the closing price on its first day of trading.\n\nAs of market creation, the IPO is scheduled to price on February 6, 2026 (ET). If no such IPO occurs by March 31, 2026, 11:59 PM ET, the market will resolve to \"No IPO before April 2026\".\n\nMarket capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.\n\nIf the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.\n\nResolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.\n\nIn the event of an interruption in the course of the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.","enableOrderBook":true,"endDate":"2026-02-06T00:00:00Z","endDateIso":"2026-02-06","featured":false,"feesEnabled":false,"funded":false,"groupItemThreshold":"2","groupItemTitle":"700M–800M","hasReviewedDates":true,"holdingRewardsEnabled":false,"icon":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","id":"1340741","image":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","lastTradePrice":0.02,"liquidity":"212.4396","liquidityClob":212.4396,"liquidityNum":212.4396,"manualActivation":false,"marketMakerAddress":"","negRisk":true,"negRiskMarketID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3400","negRiskOther":false,"negRiskRequestID":"0xe0d10ccd0d5452bc665ed26c4feed6b24b96aff4034b9b8b2544862e3cb1fd33","new":false,"oneDayPriceChange":-0.545,"orderMinSize":5,"orderPriceMinTickSize":0.01,"outcomePrices":"[\"0.43\", \"0.57\"]","outcomes":"[\"Yes\", \"No\"]","pagerDutyNotificationEnabled":false,"pendingDeployment":false,"question":"Will Agomab Therapeutics NV's market cap be between $700M and $800M at market close on IPO day?","questionID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3402","ready":false,"requiresTranslation":false,"resolvedBy":"0x2F5e3684cb1F318ec51b00Edba38d79Ac2c0aA9d","restricted":true,"rewardsMaxSpread":4.5,"rewardsMinSize":50,"rfqEnabled":false,"showGmpOutcome":false,"showGmpSeries":false,"slug":"will-agomab-therapeutics-nvs-market-cap-be-between-700m-and-800m-at-market-close-on-ipo-day","spread":0.84,"startDate":"2026-02-05T19:14:39.331681Z","startDateIso":"2026-02-05","submitted_by":"0x91430CaD2d3975766499717fA0D66A78D814E5c5","umaBond":"500","umaResolutionStatuses":"[]","umaReward":"5","updatedAt":"2026-02-06T06:38:47.278277Z","volume":"50","volume1mo":50,"volume1moClob":50,"volume1wk":50,"volume1wkClob":50,"volume1yr":50,"volume1yrClob":50,"volume24hr":50,"volume24hrClob":50,"volumeClob":50,"volumeNum":50},{"acceptingOrders":true,"acceptingOrdersTimestamp":"2026-02-05T19:13:47Z","active":true,"approved":true,"archived":false,"automaticallyActive":true,"bestAsk":0.85,"bestBid":0.01,"clearBookOnStart":true,"clobRewards":[{"assetAddress":"0x2791Bca1f2de4661ED88A30C99A7a9449Aa84174","conditionId":"0xd4b3fc35743a26fa20f75abd21c49fe7a12302d5f38550cd670ee6268e7adf01","endDate":"2500-12-31","id":"72907","rewardsAmount":0,"rewardsDailyRate":72,"startDate":"2026-02-06"}],"clobTokenIds":"[\"67684250430242977707776918320958766058547419341347467357322700114159976526319\", \"62233914669269384952222515018329679283406542594681069610999856539120728278060\"]","closed":false,"competitive":0.15921982286794706,"conditionId":"0xd4b3fc35743a26fa20f75abd21c49fe7a12302d5f38550cd670ee6268e7adf01","createdAt":"2026-02-05T17:25:02.971546Z","customLiveness":0,"cyom":false,"deploying":false,"deployingTimestamp":"2026-02-05T19:11:54.84507Z","description":"This market will resolve based on Agomab Therapeutics’ market capitalization at the closing price on its first day of trading.\n\nAs of market creation, the IPO is scheduled to price on February 6, 2026 (ET). If no such IPO occurs by March 31, 2026, 11:59 PM ET, the market will resolve to \"No IPO before April 2026\".\n\nMarket capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.\n\nIf the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.\n\nResolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.\n\nIn the event of an interruption in the course of the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.","enableOrderBook":true,"endDate":"2026-02-06T00:00:00Z","endDateIso":"2026-02-06","featured":false,"feesEnabled":false,"funded":false,"groupItemThreshold":"4","groupItemTitle":"900M–1.0B","hasReviewedDates":true,"holdingRewardsEnabled":false,"icon":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","id":"1340743","image":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","lastTradePrice":0.02,"liquidity":"212.4396","liquidityClob":212.4396,"liquidityNum":212.4396,"manualActivation":false,"marketMakerAddress":"","negRisk":true,"negRiskMarketID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3400","negRiskOther":false,"negRiskRequestID":"0x19da0ee1da0b526a24cfcbf86eda057e1eb39cf3b94b6fc396c4eba850234872","new":false,"oneDayPriceChange":-0.93,"orderMinSize":5,"orderPriceMinTickSize":0.01,"outcomePrices":"[\"0.43\", \"0.57\"]","outcomes":"[\"Yes\", \"No\"]","pagerDutyNotificationEnabled":false,"pendingDeployment":false,"question":"Will Agomab Therapeutics NV's market cap be between $900M and $1.0B at market close on IPO day?","questionID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3404","ready":false,"requiresTranslation":false,"resolvedBy":"0x2F5e3684cb1F318ec51b00Edba38d79Ac2c0aA9d","restricted":true,"rewardsMaxSpread":4.5,"rewardsMinSize":50,"rfqEnabled":false,"showGmpOutcome":false,"showGmpSeries":false,"slug":"will-agomab-therapeutics-nvs-market-cap-be-between-900m-and-1pt0b-at-market-close-on-ipo-day","spread":0.84,"startDate":"2026-02-05T19:14:53.305127Z","startDateIso":"2026-02-05","submitted_by":"0x91430CaD2d3975766499717fA0D66A78D814E5c5","umaBond":"500","umaResolutionStatuses":"[]","umaReward":"5","updatedAt":"2026-02-06T06:40:38.540917Z","volume":"50","volume1mo":50,"volume1moClob":50,"volume1wk":50,"volume1wkClob":50,"volume1yr":50,"volume1yrClob":50,"volume24hr":50,"volume24hrClob":50,"volumeClob":50,"volumeNum":50},{"acceptingOrders":true,"acceptingOrdersTimestamp":"2026-02-05T19:13:59Z","active":true,"approved":true,"archived":false,"automaticallyActive":true,"bestAsk":0.85,"bestBid":0.02,"clearBookOnStart":true,"clobRewards":[{"assetAddress":"0x2791Bca1f2de4661ED88A30C99A7a9449Aa84174","conditionId":"0x0b9a9aedacddd544bcb2906b55988310f3986f3a3f7fe1c63cca582d8588a158","endDate":"2500-12-31","id":"72914","rewardsAmount":0,"rewardsDailyRate":75,"startDate":"2026-02-06"}],"clobTokenIds":"[\"28506543423857628089456505673831255149944652278310138074485797508103557880841\", \"60710880653978663839454903237643837046470489810017411299760626827274029974471\"]","closed":false,"competitive":0.1692847718389803,"conditionId":"0x0b9a9aedacddd544bcb2906b55988310f3986f3a3f7fe1c63cca582d8588a158","createdAt":"2026-02-05T17:25:05.898974Z","customLiveness":0,"cyom":false,"deploying":false,"deployingTimestamp":"2026-02-05T19:11:54.848183Z","description":"This market will resolve based on Agomab Therapeutics’ market capitalization at the closing price on its first day of trading.\n\nAs of market creation, the IPO is scheduled to price on February 6, 2026 (ET). If no such IPO occurs by March 31, 2026, 11:59 PM ET, the market will resolve to \"No IPO before April 2026\".\n\nMarket capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.\n\nIf the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.\n\nResolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.\n\nIn the event of an interruption in the course of the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.","enableOrderBook":true,"endDate":"2026-02-06T00:00:00Z","endDateIso":"2026-02-06","featured":false,"feesEnabled":false,"funded":false,"groupItemThreshold":"6","groupItemTitle":"No IPO before April 2026","hasReviewedDates":true,"holdingRewardsEnabled":false,"icon":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","id":"1340748","image":"https://polymarket-upload.s3.us-east-2.amazonaws.com/agomab-therapeutics-ipo-closing-market-cap-n8SbcIhRPVMy.jpg","liquidity":"212.8998","liquidityClob":212.8998,"liquidityNum":212.8998,"manualActivation":false,"marketMakerAddress":"","negRisk":true,"negRiskMarketID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3400","negRiskOther":false,"negRiskRequestID":"0x379ea38ff7abc28c4c15ae6b3ca94bf2f874b9467c0d831d8615e88a825b8bfc","new":false,"oneDayPriceChange":-0.53,"orderMinSize":5,"orderPriceMinTickSize":0.01,"outcomePrices":"[\"0.435\", \"0.565\"]","outcomes":"[\"Yes\", \"No\"]","pagerDutyNotificationEnabled":false,"pendingDeployment":false,"question":"Will Agomab Therapeutics NV not IPO before April 2026?","questionID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3406","ready":false,"requiresTranslation":false,"resolvedBy":"0x2F5e3684cb1F318ec51b00Edba38d79Ac2c0aA9d","restricted":true,"rewardsMaxSpread":4.5,"rewardsMinSize":50,"rfqEnabled":false,"showGmpOutcome":false,"showGmpSeries":false,"slug":"will-agomab-therapeutics-nv-not-ipo-before-april-2026","spread":0.83,"startDate":"2026-02-05T19:15:05.32818Z","startDateIso":"2026-02-05","submitted_by":"0x91430CaD2d3975766499717fA0D66A78D814E5c5","umaBond":"500","umaResolutionStatuses":"[]","umaReward":"5","updatedAt":"2026-02-06T06:38:50.741843Z","volume":"50","volume1mo":50,"volume1moClob":50,"volume1wk":50,"volume1wkClob":50,"volume1yr":50,"volume1yrClob":50,"volume24hr":50,"volume24hrClob":50,"volumeClob":50,"volumeNum":50}],"negRisk":true,"negRiskAugmented":false,"negRiskMarketID":"0xefcef49241035e653d779817d30bf04b0ec0223859cbfeecfe7b9d33853d3400","new":false,"openInterest":0,"pendingDeployment":false,"requiresTranslation":false,"resolutionSource":"","restricted":true,"series":[{"active":true,"archived":false,"closed":false,"commentCount":0,"createdAt":"2026-02-05T17:08:17.98775Z","icon":"","id":"11134","image":"","liquidity":29112.17873,"recurrence":"weekly","requiresTranslation":false,"seriesType":"single","slug":"ipo-closing-market-cap","ticker":"ipo-closing-market-cap","title":"IPO Closing Market Cap","updatedAt":"2026-02-06T06:39:21.80593Z","volume":65023.088058,"volume24hr":31096.847933}],"seriesSlug":"ipo-closing-market-cap","showAllOutcomes":true,"showMarketImages":false,"slug":"agomab-therapeutics-ipo-closing-market-cap","startDate":"2026-02-05T19:15:59.68663Z","tags":[{"createdAt":"2023-11-02T21:20:37.488Z","forceShow":false,"id":"107","label":"Business","publishedAt":"2023-11-02 21:20:37.48+00","requiresTranslation":false,"slug":"business","updatedAt":"2026-01-24T21:03:10.539227Z"},{"createdAt":"2023-11-02T21:22:21.62Z","forceShow":false,"id":"120","isCarousel":false,"label":"Finance","publishedAt":"2023-11-02 21:22:21.615+00","requiresTranslation":false,"slug":"finance","updatedAt":"2026-01-24T21:37:56.077596Z"},{"createdAt":"2023-11-30T16:53:29.141Z","forceShow":false,"id":"600","label":"IPOs","publishedAt":"2023-11-30 16:53:29.136+00","requiresTranslation":false,"slug":"ipos","updatedAt":"2026-01-24T21:01:39.059469Z"},{"createdAt":"2025-12-30T23:31:52.33537Z","forceShow":false,"id":"103037","isCarousel":false,"label":"Climate & Science","requiresTranslation":false,"slug":"climate-science","updatedAt":"2026-01-24T21:18:27.961228Z"},{"createdAt":"2024-02-21T23:06:12.324Z","forceShow":false,"id":"1401","label":"Tech","publishedAt":"2024-02-21 23:06:12.305+00","requiresTranslation":false,"slug":"tech","updatedAt":"2026-01-24T21:03:00.008799Z"},{"createdAt":"2025-09-17T00:03:12.42045Z","id":"102599","label":"IPO","requiresTranslation":false,"slug":"ipo","updatedAt":"2026-01-24T21:36:53.004131Z"},{"createdAt":"2023-11-02T21:16:20.826Z","forceHide":true,"forceShow":false,"id":"74","label":"Science","publishedAt":"2023-11-02 21:16:20.623+00","requiresTranslation":false,"slug":"science","updatedAt":"2026-01-24T21:05:27.339038Z","updatedBy":13},{"createdAt":"2026-01-15T18:08:54.140507Z","forceShow":false,"id":"103152","isCarousel":false,"label":"Rewards 500, 4.5, 50","requiresTranslation":false,"slug":"rewards-500-4pt5-50","updatedAt":"2026-01-24T21:20:55.3079Z"}],"ticker":"agomab-therapeutics-ipo-closing-market-cap","title":"Agomab Therapeutics IPO Closing Market Cap","updatedAt":"2026-02-06T06:39:16.463212Z","volume":350,"volume1mo":350,"volume1wk":350,"volume1yr":350,"volume24hr":350}